Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET von Dunphy, Mark P.S, Lewis, Jason S

Volltext

First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET von Krebs, Simone, Veach, Darren R., Carter, Lukas M., Grkovski, Milan, Fornier, Monica, Mauro, Michael J., Voss, Martin H., Danila, Daniel C., Burnazi, Eva, Null, Manda, Staton, Kevin, Pressl, Christina, Beattie, Bradley J., Zanzonico, Pat, Weber, Wolfgang A., Lyashchenko, Serge K., Lewis, Jason S., Larson, Steven M., Dunphy, Mark P. S.

Volltext

Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer von Grkovski, Milan, Goel, Reema, Krebs, Simone, Staton, Kevin D, Harding, James J, Mellinghoff, Ingo K, Humm, John L, Dunphy, Mark PS

Volltext

Abstract 5444: Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy von Taldone, Tony, Pillarsetty, Nagavarakishore, Dunphy, Mark PS, Gerecitano, John F., Caldas-Lopes, Eloisi, Beattie, Brad, Peter, Radu I., Kang, Yanlong, Rodina, Anna, Yan, Pengrong, DaGama Gomes, Erica M., Bolaender, Alexander, Pressl, Christina, Punzalan, Blesida, Ku, Anson, Ku, Thomas, Shah, Smit, Uddin, Mohammad, Chen, Mei H., Santos, Elmer, Koziorowski, Jacek, Corben, Adriana, Modi, Shanu, Jhaveri, Komal, Lin, Oscar, Vakiani, Efsevia, Janjigian, Yelena, Zanzonico, Pat, Hudis, Clifford, Larson, Steven M., Lewis, Jason S., Chiosis, Gabriela

Volltext

Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma less than or equal to 2 cm von Nitadori, Jun-ichi, Bograd, Adam J, Morales, Eduardo A, Rizk, Nabil P, Dunphy, Mark PS, Sima, Camelia S, Rusch, Valerie W, Adusumilli, Prasad S

Volltext